BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/27/2023 11:23:27 AM | Browse: 97 | Download: 291
 |
Received |
|
2022-10-13 15:14 |
|
Peer-Review Started |
|
2022-10-13 15:17 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-11-16 13:26 |
|
Revised |
|
2022-11-23 12:00 |
|
Second Decision |
|
2023-01-12 03:31 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-01-12 20:04 |
|
Articles in Press |
|
2023-01-12 20:04 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-02-20 06:54 |
|
Publish the Manuscript Online |
|
2023-02-27 11:23 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hong-Yu Wu, Jin-Wei Li, Jin-Zheng Li, Qi-Long Zhai, Jing-Yuan Ye, Si-Yuan Zheng and Kun Fang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ningxia Hui Autonomous Region Key Research and Development Project |
2021BEG03083 |
|
| Corresponding Author |
Kun Fang, MD, Research Assistant, Surgical Oncologist, Department of Surgery, Yinchuan Maternal and Child Health Hospital, Yinchuan 750000, Ningxia Hui Autonomous Region, China. k99ftl@163.com |
| Key Words |
Borderline resectable pancreatic cancer; Neoadjuvant therapy; Resectability; Surgery; Multimodality treatment; Multidisciplinary teams. |
| Core Tip |
Borderline resectable pancreatic cancer (BRPC) is a type of pancreatic cancer with specific biological characteristics. To date, there is no unified comprehensive management for this disease. Thus, an evaluation of BRPC resection and neoadjuvant therapy (NAT) is needed. This review summarizes new resection methods and different NAT schemes, including treatment efficacy evaluation and management. This study also discusses the current progress of surgical treatment and the use of multidisciplinary teams to provide comprehensive multimodal management of BRPC treatment. |
| Publish Date |
2023-02-27 11:23 |
| Citation |
Wu HY, Li JW, Li JZ, Zhai QL, Ye JY, Zheng SY, Fang K. Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress. World J Gastrointest Surg 2023; 15(2): 142-162 |
| URL |
https://www.wjgnet.com/1948-9366/full/v15/i2/142.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v15.i2.142 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
